4
Changes in Ownership
EXELIXIS, INC. Filed Acc 0000939767-22-000122
EVP, Scientific Strategy & CSO sold 20,000 shares at $15.88 ($317,600)
- EVP, Scientific Strategy & CSO acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Lamb Peter · EVP, Scientific Strategy & CSO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-15 | Exercise or conversion : show line 1 in the form | +20,000 | $4.20 | $84,000 | 430,958 | D |
| 2022-12-15 | Sale : show line 2 in the form | −20,000 | $15.88 | $317,600 | 410,958 | D |
| Open-market sales · 20,000 sh · avg $15.88 · $317,600 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-12-15 | Exercise or conversion : show line 3 in the form Option (right to buy) | −20,000 | 20,000 | D |
Loading xslF345X03/wf-form4_167123936903484.xml…